NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Screening Protocol for the Evaluation of Potential Research Subjects

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

06-DA-N415

Sponsoring Institute

National Institute on Drug Abuse (NIDA)

Recruitment Detail

Type: No longer recruiting/follow-up only
Gender: Male & Female
Min Age: 18 Years
Max Age: 100 Years

Referral Letter Required

No

Population Exclusion(s)

Pregnant Women;
Children

Keywords

Physical Examination;
Medical Information;
Assessment;
Blood Work;
Screening

Recruitment Keyword(s)

None

Condition(s)

Addiction

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Institute on Drug Abuse

Background:

- The Neuroimaging Research Branch of the National Institute on Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addiction, and the long-term effects of drugs on the development, function, and structure of the brain and other organ systems. To develop this pool of potential participants, researchers intend to screen adolescents and adults who may be eligible for future research studies.

Objectives:

- To identify, recruit, and screen participants for NIDA neuroimaging research protocols.

Eligibility:

- Individuals 18 years of age and older who are able to provide informed consent.

Design:

- Eligible participants will undergo two screening interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview. Adolescents who are eligible for further screening must bring a parent or guardian with them to the in-person interview.

- The in-person interview may require up to five visits to the NIDA clinical center. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.

- During the screening process, participants will be explicitly asked for permission to recontact them after the 1-year duration of the screening protocol. For minors, both the adolescent and the parent/guardian must agree to future contact.

- No clinical care will be provided under this protocol.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

1. Males and females ages 18 or older.

EXCLUSION CRITERIA:

1. Phone screen: Subjects who are unable to understand or adequately answer questions posed in the phone screen.

2. Phone screen and in-person screen: Subjects unable to provide informed consent.

3. Pregnant women


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Lorenzo Leggio, M.D.
National Institute on Drug Abuse (NIDA)
NIH BIOMEDICAL RESEARCH CENTER BG RM 04A515
251 BAYVIEW BLVD.
BALTIMORE MD 21224
(240) 478-1503
lorenzo.leggio@nih.gov

NIDA IRP Screening Team
National Institute on Drug Abuse (NIDA)

(800) 535-8254
researchstudies@nida.nih.gov

NIDA IRP Screening Team

(800) 535-8254
researchstudies@nida.nih.gov

Clinical Trials Number:

NCT01036971

--Back to Top--